← Eichor
Condition: Hereditary Angioedema Type 2 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Angioedema Type 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07448181Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Phase 3 · 48 location(s) · ADARx Pharmaceuticals, Inc. · NCT07428499
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.